Citizen Scientist? 

Check out the uBiome Explorer to learn more about your microbiome.

Get sequenced

Advancing the Science
of Microbial Genomics

uBiome is the leading microbial genomics company.

We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.


Since 2012, we’ve partnered with leading researchers and organizations around the world that are involved in groundbreaking work in microbial genomics. 

Recent partnerships have included:

US Centers for Disease Control

Large-scale study of hospital patients to determine predisposing factors in the microbiome for Hospital-Acquired Infections (HAIs) and develop Microbiome Disruption Indices (MDIs).

Harvard University

Large-scale study of the relationship between genomic and microbiome data in collaboration with PI Dr. George Church.

Stanford University

Examination of the effects of chronic oral antibiotic use on the gut microbiome in acne and rosacea patients as part of our Microbiome Impact Fund program.

University of California, San Francisco

Large-scale study of the oral microbiome (in particular, the gingival sulcus) and its correlation with dental diseases, including dental caries, periodontal disease, and gingivitis with PI Dr. Jeremy Horst, DDS.

Oxford University

Crowdsourced study on the relationship between personality traits and the gut microbiome in the US, UK, and selected other countries with PI Dr. Katerina Johnson.

University of California, Berkeley

Large-scale study of obesity and the microbiome in children, their parents and siblings with a large variety of diets.

Our mission

uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.

Our story

uBiome was founded in 2012 by Stanford-, Oxford-, and UCSF-educated researchers.

Our Scientific Advisory Board includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Joel Palefsky (leading HPV expert at UCSF), Dr. George Church (leading geneticist at Harvard University), and many other leading scientists.

uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC, and other leading investors.

uBiome has been the recipient of numerous awards, including the Top 10 Most Innovative Companies in Healthcare (Fast Company), Top Prize at the IVY Awards, and CNN 10: Startups To Watch.

Nov 2012

uBiome founded with crowdfunding campaign for uBiome’s IRB-approved microbiome study, raising more than $350,000. Scientific Advisory Board includes Dr. Joseph DeRisi (MacArthur Genius), Dr. Jonathan Eisen (leading microbiologist) and others

Summer 2014

uBiome receives Series A funding from Y Combinator and Andreessen Horowitz

May 2015

uBiome has academic partnerships with leading institutions around the world, including Harvard, Stanford, UCSF, University College London, the National University of Singapore, and the Garvan Institute of Australia

Nov 2015

uBiome announces research partnership with the Centers for Disease Control and Prevention (CDC) to study hospital-acquired infections in 10,000 people

May 2016

uBiome commits more than $1 million in grant funding to support the National Microbiome Initiative

Oct 2016

uBiome clinical lab receives accreditation from the College of American Pathologists (CAP)

Oct 2016

uBiome launches SmartGut™, the first sequencing-based clinical microbiome screening test

Show More

Expanding Our Collective Understanding
of the Microbiome

The human microbiome has a profound impact on our health. It has been correlated with a wide range of conditions, including obesity and Type 2 diabetes, as well as Inflammatory Bowel Disease (IBD) and irritable bowel syndrome (IBS).

uBiome’s mission is to explore important research questions about the microbiome and develop accurate and reliable clinical tests based on the microbiome.

In the Media